The fact that the main transporter of Acetyl-CoA into the lumen of ER and lysosomes, SLC33A1, is one of the most overexpressed genes in HCC may lead to its experimental evaluation as a potential target for HCC therapy. Here, SLC33A1 is linked to hepatocellular carcinoma.